FDA Roundup
FDA Roundup
06/13/2023
This FDA Roundup includes an at-a-glance look at the latest FDA drug approvals in April and May, including treatment for menopausal hot flashes, Clostridioides difficile infection, suspected opioid...
06/13/2023
research summary
research summary
05/30/2023

Leigh Precopio

Leigh Precopio
To guide prevention efforts for fatal poisonings in pediatric patients, the authors of a recent study examined characteristics of death from poisoning in young children within the United States.
05/30/2023
FDA Alert
FDA Alert
05/27/2023

Jessica Ganga

Jessica Ganga
The FDA’s approval of nalmefene hydrochloride nasal spray marks the first of its kind for health care and community use.
05/27/2023
conference coverage
conference coverage
04/17/2023

Leigh Precopio

Leigh Precopio
In a recent study presented at the Hematology/Oncology Pharmacy Association annual conference, researchers examined the use of opioids in patients with head and neck squamous cell carcinoma while undergoing...
04/17/2023
FDA Alerts
FDA Alerts
04/03/2023

Jessica Ganga

Jessica Ganga
The FDA approves the overdose medication for over-the-counter use after data supports its safe use.
04/03/2023
Research Summary
Research Summary
01/23/2023
Researchers examined the implementation of a restricted opioid prescribing plan for patients who experienced pain post-surgery in efforts to reduce chronic opioid use.
01/23/2023
pain management
pain management
08/31/2022
The researchers examined trends in opioid prescribing in the United States as professional organizations update their pain management guidelines to reduce opioid use.
08/31/2022
opioids
opioids
03/02/2022
In a recent study, researchers compared the efficacy of a mindfulness-based treatment vs group psychotherapy for patients with chronic pain and misusing opioids.
03/02/2022
opioid
opioid
11/08/2018
Excessive opioid prescribing is associated with higher patient-re
11/08/2018
opioid
opioid
06/15/2018
In an effort to improve access to prevention and treatment for opioid dependence, the FDA has prioritized the approval of generic versions of medication-assisted treatment options.
06/15/2018